This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Targeting human T‐lymphotropic virus type 1‐infected cells with an anti‐C‐C chemokine receptor 4 antibody in T‐lymphotropic virus type 1‐associated myelopathy. Issue 3 (3rd June 2018)
Record Type:
Journal Article
Title:
Targeting human T‐lymphotropic virus type 1‐infected cells with an anti‐C‐C chemokine receptor 4 antibody in T‐lymphotropic virus type 1‐associated myelopathy. Issue 3 (3rd June 2018)
Main Title:
Targeting human T‐lymphotropic virus type 1‐infected cells with an anti‐C‐C chemokine receptor 4 antibody in T‐lymphotropic virus type 1‐associated myelopathy
Abstract : In this article, we introduce our findings from phase I/IIa trial of anti‐CCR4 antibody in patients with HAM/TSP. The study demonstrated the importance of targeting HTLV‐1‐infected cells for the treatment of HAM/TSP.